FR2767136B1 - Recepteur complexe lsr, activite, clonage, et applications au diagnostic, a la prevention et/ou au traitement de l'obesite et des risques ou complications associes - Google Patents

Recepteur complexe lsr, activite, clonage, et applications au diagnostic, a la prevention et/ou au traitement de l'obesite et des risques ou complications associes

Info

Publication number
FR2767136B1
FR2767136B1 FR9710088A FR9710088A FR2767136B1 FR 2767136 B1 FR2767136 B1 FR 2767136B1 FR 9710088 A FR9710088 A FR 9710088A FR 9710088 A FR9710088 A FR 9710088A FR 2767136 B1 FR2767136 B1 FR 2767136B1
Authority
FR
France
Prior art keywords
obesity
complications
cloning
diagnosis
prevention
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9710088A
Other languages
English (en)
Other versions
FR2767136A1 (fr
Inventor
Bernard Bihain
Lydie Bougueleret
Potin Frances Yen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Biodevelopment SAS
Original Assignee
Genset SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genset SA filed Critical Genset SA
Priority to FR9710088A priority Critical patent/FR2767136B1/fr
Priority to FR9805032A priority patent/FR2767135B1/fr
Priority to EP07120518A priority patent/EP1903057B1/fr
Priority to PCT/IB1998/001256 priority patent/WO1999007736A2/fr
Priority to CA002298849A priority patent/CA2298849A1/fr
Priority to DE69841186T priority patent/DE69841186D1/de
Priority to CA002274302A priority patent/CA2274302A1/fr
Priority to EP03102647A priority patent/EP1375516A3/fr
Priority to DE69838720T priority patent/DE69838720T2/de
Priority to DK98936611T priority patent/DK0964870T3/da
Priority to DK98936610T priority patent/DK1003783T3/da
Priority to PT98936611T priority patent/PT964870E/pt
Priority to AT98936610T priority patent/ATE378354T1/de
Priority to ES98936611T priority patent/ES2210786T3/es
Priority to EP98936611A priority patent/EP0964870B1/fr
Priority to AU85564/98A priority patent/AU745607C/en
Priority to DE69820419T priority patent/DE69820419T2/de
Priority to ES98936610T priority patent/ES2296339T3/es
Priority to AT07120518T priority patent/ATE443721T1/de
Priority to EP98936610A priority patent/EP1003783B1/fr
Priority to PT98936610T priority patent/PT1003783E/pt
Priority to PCT/IB1998/001257 priority patent/WO1999007737A2/fr
Priority to AU85563/98A priority patent/AU754942B2/en
Priority to US09/485,316 priority patent/US6344441B1/en
Priority to AT98936611T priority patent/ATE256146T1/de
Priority to US09/269,939 priority patent/US6635431B1/en
Priority to JP2000506238A priority patent/JP2001512746A/ja
Priority to JP51192099A priority patent/JP3726969B2/ja
Publication of FR2767136A1 publication Critical patent/FR2767136A1/fr
Priority to US10/060,845 priority patent/US6946444B2/en
Priority to US10/072,159 priority patent/US7220722B2/en
Priority to US10/650,507 priority patent/US7291709B2/en
Publication of FR2767136B1 publication Critical patent/FR2767136B1/fr
Application granted granted Critical
Priority to JP2004355464A priority patent/JP2005143508A/ja
Priority to US11/741,979 priority patent/US20080249009A1/en
Priority to US11/862,842 priority patent/US7919091B2/en
Priority to CY20071101489T priority patent/CY1107808T1/el
Priority to US13/020,359 priority patent/US20110165166A1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR9710088A 1997-08-06 1997-08-06 Recepteur complexe lsr, activite, clonage, et applications au diagnostic, a la prevention et/ou au traitement de l'obesite et des risques ou complications associes Expired - Fee Related FR2767136B1 (fr)

Priority Applications (36)

Application Number Priority Date Filing Date Title
FR9710088A FR2767136B1 (fr) 1997-08-06 1997-08-06 Recepteur complexe lsr, activite, clonage, et applications au diagnostic, a la prevention et/ou au traitement de l'obesite et des risques ou complications associes
FR9805032A FR2767135B1 (fr) 1997-08-06 1998-04-22 Recepteur complexe lsr, activite, clonage, et application au diagnostic, a la prevention et/ou au traitement de d'obesite et des risques ou complications associes
AU85564/98A AU745607C (en) 1997-08-06 1998-08-06 LSR receptor, activity, cloning, and uses for diagnosing, preventing and/or treating obesity and related risks or complications
CA002298849A CA2298849A1 (fr) 1997-08-06 1998-08-06 Medicaments regulant les lipoproteines
DE69841186T DE69841186D1 (de) 1997-08-06 1998-08-06 Lipoprotein-regulierende Medikamente
CA002274302A CA2274302A1 (fr) 1997-08-06 1998-08-06 Recepteur lsr, activite, clonage, et applications au diagnostic, a la prevention et/ou au traitement de l'obesite et des risques ou complications associes
EP03102647A EP1375516A3 (fr) 1997-08-06 1998-08-06 Méthode de production d'un polypeptide recombinant du récepteur LSR
DE69838720T DE69838720T2 (de) 1997-08-06 1998-08-06 Lipoprotein-regulierende arzneimittel
DK98936611T DK0964870T3 (da) 1997-08-06 1998-08-06 LSR-receptor, kloning og anvendelser
DK98936610T DK1003783T3 (da) 1997-08-06 1998-08-06 Lipoproteinregulerende medikamenter
PT98936611T PT964870E (pt) 1997-08-06 1998-08-06 Receptor lsr actividade clonagem e aplicacoes ao diagnostico a prevencao e/ou ao tratamento da obesidade e dos riscos ou complicacoes associadas
AT98936610T ATE378354T1 (de) 1997-08-06 1998-08-06 Lipoprotein-regulierende arzneimittel
ES98936611T ES2210786T3 (es) 1997-08-06 1998-08-06 Receptor lsr, clonacion y aplicaciones.
EP98936611A EP0964870B1 (fr) 1997-08-06 1998-08-06 Recepteur lsr, clonage et applications
AU85563/98A AU754942B2 (en) 1997-08-06 1998-08-06 Lipoprotein-regulating medicaments
DE69820419T DE69820419T2 (de) 1997-08-06 1998-08-06 Klonierung und verwendung des lsr-rezeptors
ES98936610T ES2296339T3 (es) 1997-08-06 1998-08-06 Medicamentos que regulan las lipoproteinas.
AT07120518T ATE443721T1 (de) 1997-08-06 1998-08-06 Lipoprotein-regulierende medikamente
EP07120518A EP1903057B1 (fr) 1997-08-06 1998-08-06 Médicaments à régulation de lipoprotéine
EP98936610A EP1003783B1 (fr) 1997-08-06 1998-08-06 Medicaments regulant les lipoproteines
PCT/IB1998/001257 WO1999007737A2 (fr) 1997-08-06 1998-08-06 Recepteur lsr, clonage et applications
PCT/IB1998/001256 WO1999007736A2 (fr) 1997-08-06 1998-08-06 Medicaments regulant les lipoproteines
US09/485,316 US6344441B1 (en) 1997-08-06 1998-08-06 Lipoprotein-regulating medicaments
AT98936611T ATE256146T1 (de) 1997-08-06 1998-08-06 Klonierung und verwendung des lsr-rezeptors
US09/269,939 US6635431B1 (en) 1997-08-06 1998-08-06 LSR receptor, activity, cloning, and uses for diagnosing, preventing and/or treating obesity and related risks or complications
JP2000506238A JP2001512746A (ja) 1997-08-06 1998-08-06 リポタンパク質調節用医薬
JP51192099A JP3726969B2 (ja) 1997-08-06 1998-08-06 Ｌｓｒ受容体、その活性、そのクローニングならびにその肥満および関連する危険性または合併症の診断、予防および／または治療への応用
PT98936610T PT1003783E (pt) 1997-08-06 1998-08-06 Medicamentos reguladores de lipoproteínas
US10/060,845 US6946444B2 (en) 1997-08-06 2002-01-29 Lipoprotein-regulating medicaments
US10/072,159 US7220722B2 (en) 1997-08-06 2002-02-05 Lipoprotein-regulating medicants
US10/650,507 US7291709B2 (en) 1997-08-06 2003-08-27 LSR receptor, its activity, its cloning, and its applications to the diagnosis, prevention and/or treatment of obesity and related risks or complications
JP2004355464A JP2005143508A (ja) 1997-08-06 2004-12-08 Ｌｓｒ受容体、その活性、そのクローニングならびにその肥満および関連する危険性または合併症の診断、予防および／または治療への応用
US11/741,979 US20080249009A1 (en) 1997-08-06 2007-04-30 Lipoprotein-Regulating Medicaments
US11/862,842 US7919091B2 (en) 1997-08-06 2007-09-27 Lipolysis stimulated receptor (LSR) specific antibodies
CY20071101489T CY1107808T1 (el) 1997-08-06 2007-11-20 Φaρμακα ρυθμiζοντα τις λιποπρωτεïνες
US13/020,359 US20110165166A1 (en) 1997-08-06 2011-02-03 Lsr receptor, its activity, its cloning, and its applications to the diagnosis, prevention and/or treatment of obesity and related risks or complications

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9710088A FR2767136B1 (fr) 1997-08-06 1997-08-06 Recepteur complexe lsr, activite, clonage, et applications au diagnostic, a la prevention et/ou au traitement de l'obesite et des risques ou complications associes

Publications (2)

Publication Number Publication Date
FR2767136A1 FR2767136A1 (fr) 1999-02-12
FR2767136B1 true FR2767136B1 (fr) 2004-08-27

Family

ID=9510093

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9710088A Expired - Fee Related FR2767136B1 (fr) 1997-08-06 1997-08-06 Recepteur complexe lsr, activite, clonage, et applications au diagnostic, a la prevention et/ou au traitement de l'obesite et des risques ou complications associes

Country Status (1)

Country Link
FR (1) FR2767136B1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2323445T3 (es) * 1999-02-10 2009-07-16 Serono Genetics Institute S.A. Marcadores polimorficos del gen lsr.
GB9920334D0 (en) 1999-08-28 1999-11-03 Glaxo Group Ltd Method

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5691447A (en) * 1995-03-24 1997-11-25 Tanox Biosystems, Inc. GC1q receptor, HIV-1 gp120 region binding thereto, and related peptides and targeting antibodies
ATE320479T1 (de) * 1996-01-23 2006-04-15 Indevus Pharmaceuticals Inc Process zur verwendung des obese-gens und seines genprodukts zur stimulierung der entwicklung von haemotopoietischen zellen

Also Published As

Publication number Publication date
FR2767136A1 (fr) 1999-02-12

Similar Documents

Publication Publication Date Title
DE69632601D1 (de) Auf Kodes für Herzschläge basierendes Gerät für Diagnose und Behandlung von Herzarryhythmie
DE69702845D1 (de) Sich auf prioritätsregeln beziehendes gerät für diagnose und behandlung von herzarhythmie
DE69529307T2 (de) Ultraschall-Diagnose- und Behandlungssystem
DE69728323D1 (de) Variante des humanen C3a Rezeptors; diagnostische und therapeutische Verwendungen
FR2776912B1 (fr) DISPOSITIF D'EXPLOITATION PER OPERATOIRE DE l'APPAREIL CARDIO-CIRCULATOIRE DU CORPS HUMAIN OU ANIMAL
CA2312729A1 (fr) Utilisation de 9-desoxy-2', 9-.alpha.-methano-3- oxa-4,5,6- trinor-3, 7-(1',3'-interphenylene) -13,14-dihydro- prostaglandine f1 dans le cadre du traitement de l'acrosyndrome vasculaire
FR2596992B1 (fr) Sel de lysine du complexe gadolinium-dota et ses applications au diagnostic
EP1382616A3 (fr) Préparations pharmaceutiques pour le traitement des anormalités associées à l'activité d'un récepteur humain y5
CH1143977H1 (fr) 2-Oxy-benzoxazine-4-ones destinees au traitement de l'obesite
HUP0003852A3 (en) Use of highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of alzheimer's disease and dementias
NO994915L (no) Fremgangsmåter for diagnostisering av kliniske undertyper av Crohn's sykdom med karakteristisk evne til å gi respons på anti-Thl-cytokinterapi
DE69837968D1 (de) Diagnose und behandlung myocardieller fehler
DE60022754D1 (de) Diagnose und behandlung von arrhythmien
DE69429202D1 (de) Therapeutischer Wirkstoff für Erkrankungen des Verdauungstraktes
FR2736261B1 (fr) Produit d'hygiene capillaire ou de traitement pileux
FR2767040B1 (fr) Dispositif pour le traitement et/ou le maquillage des fibres keratiniques
ATE282400T1 (de) Oxidationszusammensetzung und verwendungen derselben für die behandlung von keratinischen fasern
FR2767136B1 (fr) Recepteur complexe lsr, activite, clonage, et applications au diagnostic, a la prevention et/ou au traitement de l'obesite et des risques ou complications associes
NO20015653D0 (no) Diagnose og behandling av aterosklerose og koronar hjertelidelse
MA26645A1 (fr) Composes destines au traitement des troubles psychiotriques, neurologiques et physiologiques lies au recepteur de l'orphanine fq
FR2744361B1 (fr) Application de derives de pyrrolidine a la preparation de medicaments destines au traitement de l'abus de drogues ou de substances donnant lieu a des pharmacomanies ou a un usage excessif
FR2778207B1 (fr) Pot catalytique et de traitement acoustique d'une ligne d'echappement a double flux
FR2795323B1 (fr) Utilisation de ligands melatoninergiques pour l'obtention de compositions pharmaceutiques destinees a la prevention ou au traitement des pathologies du systeme gastrointestinal
FR2758144B1 (fr) Polynucleotide codant pour un polypeptide de 27 kd de mycobacteries appartenant au complexe de mycobacterium tuberculosis, application au diagnostic et a la prevention de la tuberculose
FR2756737B1 (fr) Application de la thalidomide au traitement de la maladie de parkinson et des syndromes parkinsoniens

Legal Events

Date Code Title Description
CA Change of address
ST Notification of lapse

Effective date: 20110502